Last edition
News about
Novo Nordisk Launches Wegovy Weight-Loss Pill in UAE, First Market Outside the US
UAE becomes first country outside the United States to offer the oral semaglutide treatment for obesity, marking a key step in Novo Nordisk’s global expansion plans.
Next-generation Nanomedicine can Silence Key Cancer Drivers: Research
Scientists in Pune have developed a next-generation precision nanomedicine that uses gene-silencing technology to target key cancer drivers and effectively inhibit breast tumor growth, highlighting a promising new approach for targeted breast cancer treatment and precision oncology.
US FDA Releases Draft Guidance to Accelerate Cell and Gene Therapy Development
The US FDA has issued draft guidance aimed at accelerating the development of cell and gene therapies by enabling sponsors to leverage existing scientific evidence, reduce redundant testing for treatments targeting rare and life-threatening diseases.
WHO Invites Medicine Submissions to Expand Substance Use Disorder Treatment
The World Health Organization (WHO) has invited manufacturers to submit medicines for prequalification to help expand access to treatments for substance use disorders, addressing a major global public health challenge.
SCHOTT Pharma Expands Vial Manufacturing Capacity in Lebanon
SCHOTT Pharma inaugurates new capacity for core and specialty vials at its site in Lebanon, supporting future growth in the region. The state-of-the-art equipment sets new quality and automation standards for High-Value Solutions (HVS) in the US.
J&J Introduces VARIPULSE Platform for Atrial Fibrillation Treatment in India
Johnson & Johnson has launched the VARIPULSE platform in India, introducing Pulsed Field Ablation (PFA) technology for catheter ablation procedures in patients with atrial fibrillation (AFib).
Lupin and Natco Secure USFDA Approval for Generic Cancer Drug Eribulin Mesylate Injection
Lupin and Natco Pharma have received USFDA approval for Eribulin Mesylate Injection, a generic equivalent of Halaven, used in the treatment of advanced breast cancer and liposarcoma.
Novartis Reports Strong Long-Term Efficacy of Scemblix in Chronic Myeloid Leukemia Trial
Novartis’ Scemblix demonstrated sustained efficacy and a favourable safety profile over nearly three years of follow-up, reinforcing its potential as a frontline treatment option for adults with Philadelphia chromosome-positive chronic myeloid leukemia.
iiCON Secures European Funding to Lead Pan-European Network on Infectious Disease Preparedness
iiCON will lead a Europe-wide collaboration bringing together researchers, healthcare experts, policymakers and industry partners to develop coordinated solutions for emerging infectious disease threats.
Alkem Brings Semaglutide Pre-Filled Syringes to Indian Market
Alkem has launched semaglutide pre-filled syringes in India, introducing a convenient single-shot administration option for the management of Type 2 Diabetes (T2D) and obesity.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy